clinical specialties are trauma surgery and surgical critical care. His research focuses on identifying best resuscitation strategies for hemorrhagic shock, the early prediction of patients who will receive massive transfusion of blood and blood products, and use of thrombelastography to guide resuscitation and correct coagulopathy following injury.

Recently, he has investigated how best to manage severe bleeding in patients taking newer oral anticoagulants. Dr. Cotton holds funding from the National Institutes of Health, the State of Texas Emerging Technologies Fund and the Department of Defense.

Dr. Cotton is on faculty at the Center for Translational Injury Research in Houston and is the Director of the Surgical Critical Care, Trauma Surgery and Acute Care Surgery Fellowships at UT-Houston. He is a member of numerous societies, including the American Association for theSurgery of Trauma, the Society of University Surgeons and the Southern Surgical Association. He is also a Fellow of the American College of Surgeons and the Royal College of Surgeons and Physicians-Glasgow.

NICK CURZEN, BM, PhD

Dr. Curzen focuses on coronary intervention and trans-catheter aortic valve implantation (TAVI). He has an active research team focusing on coronary physiology, computer modelling in coronary stents and TAVI, and platelet function. He is currently Chief Investigator for two large randomized trials in the UK: RIPCORD 2 and FORECAST. Previously, he was Chief Investigator for RIPCORD 1, FFRCT RIPCORD and COMET.

Dr. Curzen has led a platelet function research team for over 10 years looking at personalized antiplatelet medication, and has published widely in this field using TEG 5000. More recently, the team has just